Cancer Research AACR Legacy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menke, A. L.
Right arrow Articles by Hastie, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menke, A. L.
Right arrow Articles by Hastie, N. D.
[Cancer Research 62, 6615-6620, November 15, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Genetic Interactions between the Wilms’ Tumor 1 Gene and the p53 Gene1

Aswin L. Menke2, Alan R. Clarke, Andrea Leitch, Annemieke Ijpenberg, Kathy A. Williamson, Lee Spraggon, David J. Harrison and Nicholas D. Hastie

Central Hematologie Laboratory, University Medical Centre St. Radboud, 6500 HB, Nijmegen, the Netherlands [A. L. M.]; Medical Research Council Human Genetics Unit, Western General Hospital, EH4 2XU, Edinburgh, United Kingdom [A. L., A. I., K. A. W., L. S., N. D. H.]; Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3US, United Kingdom [A. R. C.]; and Department of Pathology, University Medical School, Edinburgh, EH8 9AG, United Kingdom [D. J. H.]

In recent years, a number of proteins have been identified that can modify the activities of the Wilms’ Tumor 1 (WT1) proteins. One of these modifiers is the p53 protein. To investigate a genetic interaction between the p53 gene and the wt1 gene, we have crossed their respective knockout mice. The absence of p53 appears to have no gross effect on the phenotype of wt1-null mice. Both wt1-null and double-null embryos develop pericardial bleeding and die in utero. In adult p53-null mice, wt1-heterozygosity (wt1het) predisposes to an earlier onset of lymphomagenesis and the development of kidney abnormalities resembling oncocytoma in humans. wt1-heterozygosity alone predisposes to the development of glomerular sclerosis.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H.-S. Kim, M. S. Kim, A. L. Hancock, J. C. P. Harper, J. Y. Park, G. Poy, A. O. Perantoni, M. Cam, K. Malik, and S. B. Lee
Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development
J. Biol. Chem., June 1, 2007; 282(22): 16278 - 16287.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. T. Discenza and J. Pelletier
Insights into the physiological role of WT1 from studies of genetically modified mice
Physiol Genomics, February 13, 2004; 16(3): 287 - 300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.